海外の治験の状況「1」での検索結果
2657件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Daily disposable trial:Prospective, open label, randomised, cross-over clinical trial to evaluate the performance of Focus (registered trademark) 1-2 Week, Focus(registered trademark) Monthly and FreshLook (registered trademark) Handling Tint contact lenses on a daily wear, daily disposable wear schedule in neophyte and experienced East Asian wearers.
- Evaluation of the vision, fitting characteristics, ocular and subjective responses of commercially available lenses made from Vifilcon A (Focus 1-2 Week, Focus Monthly) and Phemfilcon A (Freshlook Handling Tint).
- Australia
- 2010-01-04
Not recruiting
- Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
- Childhood Hepatocellular Carcinoma;Papillary Thyroid Cancer;Previously Treated Childhood Rhabdomyosarcoma;Recurrent Childhood Liver Cancer;Recurrent Childhood Rhabdomyosarcoma;Recurrent Thyroid Cancer;Recurrent Wilms Tumor and Other Childhood Kidney Tumors
- Australia, Canada, United States
- 2011-12-29
Not recruiting
- Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)
- Post-transplantation Lymphoproliferative Disorder
- Australia, France, Germany, Sweden
- 2011-10-18
Not recruiting
- Phase 1 Study to Evaluate the PK, Safety, and Tolerability of BG00012 in Chinese, Japanese, and Caucasian Healthy Volunteers
- Healthy
- Australia, China
- 2011-10-13
Not recruiting
- Comparison of fingerprick blood glucose levels and continuous glucose monitoring to assess high and low blood sugar levels in hospitalized patients treated with basal bolus insulin.
- Management of glycaemic control in hospitalised diabetic patients;diabetes
- Australia
- 2011-08-31
Not Recruiting
- Study of a new factor VIII replacement for patients with congenital hemophilia A
- Congenital Hemophilia A with factor VIII inhibitors MedDRA version: 14.1 Level: LLT Classification code 10018938 Term: Haemophilia A (Factor VIII) System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Canada, South Africa, United Kingdom, United States
- 2011-07-18
Not recruiting
- Transdiagnostic Program 1 - The Anxiety Program: Internet based education for social phobia, panic disorder (with or without agoraphobia) and generalised anxiety disorder with telephone reminders and online forum support. A randomized controlled study
- Social phobia (an anxiety disorder);Panic disorder (with or without agoraphobia) (both anxiety disorders);Generalised anxiety disorder (an anxiety disorder)
- Australia
- 2011-06-20
Recruiting
- A clinical trial to study the effects and the antiviral activity of TMC278 in HIV-1 infected adolescent patients aged 12 to 18 years
- HIV 1 infected adolescents
- India, South Africa, Thailand, Uganda, United States of America
- 2011-06-10
Not Recruiting
- A 1 year follow-up research project for children with pulmonary arterial hypertension (PAH) that participated in the FUTURE 3 core study. This is to find out how well bosentan is tolerated and safe when taken either two or three times a day
- Pulmonary arterial hypertension (PAH) in children MedDRA version: 16.1 Level: LLT Classification code 10064910 Term: Familial (FPAH) System Organ Class: 100000004855 MedDRA version: 16.1 Level: LLT Classification code 10064909 Term: Idiopathic (IPAH) System Organ Class: 100000004855 MedDRA version: 16.1 Level: LLT Classification code 10064908 Term: Associated with (APAH) System Organ Class: 100000004855 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Australia, Belarus, China, Czech Republic, France, Germany, Hungary, India, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Serbia, South Africa, Spain, Ukraine, United States
- 2011-02-01
Not Recruiting
- A Multicenter Trial Comparing REMICADE (infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence
- Crohn’s disease (CD) MedDRA version: 16.1 Level: PT Classification code 10011401 Term: Crohn's disease System Organ Class: 10017947 - Gastrointestinal disorders ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Australia, Austria, Belgium, Czech Republic, Denmark, France, Germany, Hungary, Israel, Italy, Netherlands, New Zealand, Poland, United Kingdom
- 2010-06-24
Not Recruiting
- A Phase 1/2a, Open Label, Dose Escalation, Safety Study of Intra-thrombus Plasmin (Human) Administration in Acute, Middle Cerebral Artery, Ischemic Stroke
- Thrombus in acute ischemic stroke of the middle cerebral artery MedDRA version: 14.1 Level: PT Classification code 10008190 Term: Cerebrovascular accident System Organ Class: 10029205 - Nervous system disorders
- Australia, Austria, France, Germany, Israel, Serbia, Slovakia, Spain, United Kingdom
- 2009-07-02
Not recruiting
- A randomised controlled trial comparing the clinical efficacy of internet-delivered cognitive behavioural therapy for perinatal anxiety and depression to treatment as usual. Study 1: The Perinatal MUMentum Program: Pregnancy Course
- Anxiety during pregnancy ;Depression during pregnancy
- Australia
- 2016-05-02
Not recruiting
- A phase 2, randomised, double-blind, placebo-controlled, adaptive design study investigating the safety and effectiveness of orally administered BGP-15 on cardiac fibrosis and heart function in people with Non-Ischaemic Dilated Cardiomyopathy (NIDCM)
- Non-ischemic dilated cardiomyopathy;Cardiac fibrosis
- Australia
- 2016-04-13
Recruiting
- Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
- Autoimmune Pulmonary Alveolar Proteinosis;Autoimmune Pulmonary Alveolar Proteinosis;Autoimmune Pulmonary Alveolar Proteinosis
- Australia, Denmark, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Switzerland, Turkey, United Kingdom, United States
- 2016-02-28
Not Recruiting
- A study comparing the use of etanercept and methotrexate, used either alone or in combination for the treatment of Psoriatic Arthritis.
- Psoriatic arthritis MedDRA version: 19.1 Level: LLT Classification code 10037160 Term: Psoriatic arthritis System Organ Class: 100000004859 ;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Argentina, Bulgaria, Canada, Chile, Czech Republic, France, Greece, Hungary, Latvia, Mexico, Poland, Portugal, Russian Federation, South Africa, Spain, United States
- 2015-11-27
Authorised
- EFFICACY AND SAFETY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN SUBJECTS =1 MONTH TO <4 YEARS WITH PARTIAL-ONSET SEIZURES
- Epilepsy with partial onset seizures MedDRA version: 18.0 Level: PT Classification code 10015037 Term: Epilepsy System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Australia, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czech Republic, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Korea, Republic of, Lithuania, Mexico, Moldova, Republic of, Poland, Romania, Serbia, Spain, Taiwan, Thailand, Ukraine, United Kingdom, United States
- 2015-03-10
Authorised
- A Phase 1 dose-finding and Phase 2 randomized double-blinded study evaluating if veliparib compared to placebo improves efficacy of caboplatin and etoposide combination in patients with untreated extensive stage small cell lung cancer
- Extensive Stage Disease Small Cell Lung Cancer (ED SCLC) MedDRA version: 17.0 Level: PT Classification code 10041068 Term: Small cell lung cancer extensive stage System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belarus, Canada, Korea, Democratic People's Republic of, Netherlands, New Zealand, Puerto Rico, Russian Federation, Spain, Taiwan, United States
- 2014-09-22
Not Recruiting
- Impact of Inspiratory Muscle Training versus Resistance Training on ventricular dysfunction for patients with Dilated Cardiomyopathy: Randomized Contr
- Circulatory System Dilated Cardiomyopathy;Circulatory System;Dilated Cardiomyopathy
- Egypt
- 2017-06-19
Not recruiting
- A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers
- Irritable Bowel Syndrome
- Australia
- 2017-05-12
Not Recruiting
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety and Tolerability of TMC435 vs Placebo as Part of a Treatment Regimen Including Peginterferon a-2a and Ribavirin in Hepatitis C, Genotype 1 Infected Subjects Who Relapsed After Previous Interferon-based Therapy
- Hepatitis C;B18.2 - Chronic viral hepatitis C
- Australia, Austria, Belgium, Canada, France, Germany, New Zealand, Poland, Puerto Rico, Russian Federation, Spain, United Kingdom, United States
- 2017-05-10
